When is Cimzia Expected to Lose Exclusivity?
Cimzia (certolizumab pegol) is currently expected to face loss of exclusivity (LOE) in 2024 [1]. This projection is based on the expiration of key patents protecting the drug.
What Drives Loss of Exclusivity for Cimzia?
Loss of exclusivity for Cimzia is primarily driven by patent expirations [1]. Once patents expire, other companies may be able to develop and market generic or biosimilar versions of the drug. This typically leads to increased competition and a decrease in the originator drug's market share and price.
How Do Patent Expirations Affect Cimzia's Market?
The expiration of patents for Cimzia will likely open the door for the introduction of biosimilars [1]. Biosimilars are biological products that are highly similar to an already approved biologic drug, demonstrating no clinically meaningful differences in terms of safety, purity, and potency. The availability of biosimilars can significantly impact the market by offering more affordable treatment options for patients and healthcare systems.
When Does Cimzia's Core Patent Expire?
A key patent for Cimzia, U.S. Patent No. 7,777,098, is set to expire in late 2024 [1]. This patent is crucial for the drug's market exclusivity.
Are There Other Patents or Exclusivities for Cimzia?
While the '098 patent is a primary driver, there may be other patents and exclusivities related to Cimzia's formulation, manufacturing processes, or methods of use. These can sometimes extend market protection beyond the expiration of core composition-of-matter patents. However, the 2024 date is the most significant milestone for anticipated LOE [1].
What Happens After Cimzia Loses Exclusivity?
Following Cimzia's loss of exclusivity, the market is likely to see the introduction of biosimilar competitors [1]. This increased competition is expected to lead to price reductions and potentially greater access to treatment for patients. The specific timeline for biosimilar market entry can depend on regulatory approvals and any ongoing patent litigation.
Who Manufactures Cimzia?
Cimzia is manufactured by UCB [2].